Simplexa Flu A/B & RSV Kit
Simplexa Flu A/B & RSV Kit
Background
The CDC estimates that influenza has resulted in up to 35.6 million illnesses, 710,000 hospitalizations, and as many as 56,000 deaths annually since 2010.
Respiratory syncytial virus (RSV) infection is more prevalent in infants and toddlers and is a leading cause of hospitalization in this age group, but RSV also causes disease in adults that can be severe in certain populations.
Why to choose it
Capable of running 94 patient samples at the same time
Benefits
92 strains have been validated, with more strains tested regularly to provide confidence in your results
CURRENT STRAIN MONITORING
| 2016/201/ VACCINE STRAINS | 2017/2018 VACCINE STRAINS |
A/California/7/2009 | A/Michigan/45/2015 |
A/Hong Kong/4801/2014 | A/Hong Kong/4801/2014 |
B/Brisbane/60/2008-like virusV | B/Brisbane/60/2008-like virusV |
B/Phuket/3073/2013-like virus V* | B/Phuket/3073/2013-like virus V* |
V= Validated and in FDA cleared PI
T= Tested but not submitted to FDA to revise PI
R= Recently ordered from IRR will be tested
*in quadrivalent vaccine
Reliability
Simplexa Flu A/B & RSV assay has 100% sensitivity and greater than 98% specificity.
SIMPLEXA FLU A/B AND CULTURE/DFA CLINICAL AGREEMENT
INFLUENZA A
| Clinical Agreement | Prospective Samples | Retrospective Samples |
| Sensitivity | 100% | 100% |
| Specificity | 99.3% | 100% |
INFLUENZA B
| Clinical Agreement | Prospective Samples | Retrospective Samples |
| Sensitivity | 100% | 100% |
| Specificity | 99.8% | 100% |
RSV
| Clinical Agreement | Prospective Samples | Retrospective Samples |
| Sensitivity | 98.0% | 100% |
| Specificity | 96.9% | 96.0% |
For use on
Ordering Info
| PRODUCT | CODE | REACTIONS |
| Simplexa Flu A/B & RSV Kit | MOL2600 | 100 |
Please click below for more information
Simplexa Flu A/B & RSV Direct Kit Brochure
- Product: Simplexa Flu A/B & RSV Kit
- SKU:
- Availability: In Stock